Author

E. Philip Horwitz

Harvard UniversityORCID 0000-0003-0361-3374Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aditya BardiaiD· 1 shared Annamária SzabolcsiD· 1 shared Ben S. WittneriD· 1 shared Brian Chirn· 1 shared Daniel A. HaberiD· 1 shared Dante Che· 1 shared David Tsai TingiD· 1 shared Devon F. WileyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aditya BardiaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedJul 7, 2025

CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors.

E. Philip Horwitz, Taronish D. Dubash, Annamária Szabolcs…·Daniel A. Haber

This study identifies CDKN1B as a regulator of drug-tolerant persister CTCs by preventing polyploidy after mitotic inhibitor treatment in breast cancer.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky